Original
Documento de consenso sobre los medicamentos biosimilares en enfermedades inmunomediadas en España
Consensus statement on the use of biosimilar drugs in immune-mediated diseases in Spain
Emilio Monte-Boqueta,
, Ángeles Florezb, Guillermo José Alcaín Martínezc, Agustí Sellasd
Corresponding author
a Servicio de Farmacia, Hospital Universitario y Politécnico La Fe, Valencia, España
b Servicio de Dermatología, Complejo Hospitalario Universitario de Pontevedra, Pontevedra, España
c Unidad de Gestión Clínica de Aparato Digestivo, Hospital Universitario Virgen de la Victoria, Málaga, España
d Servicio de Reumatología, Hospital Universitari Arnau de Vilanova, Lleida, España
Read
3359
Timeswas read the article
984
Total PDF
2375
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 11 | 106 | 21 | 127 |
| 2025 10 | 18 | 71 | 89 |
| 2025 9 | 0 | 66 | 66 |
| 2025 8 | 0 | 86 | 86 |
| 2025 7 | 0 | 63 | 63 |
| 2025 6 | 9 | 33 | 42 |
| 2025 5 | 155 | 53 | 208 |
| 2025 4 | 199 | 54 | 253 |
| 2025 3 | 140 | 44 | 184 |
| 2025 2 | 188 | 41 | 229 |
| 2025 1 | 165 | 52 | 217 |
| 2024 12 | 207 | 32 | 239 |
| 2024 11 | 311 | 60 | 371 |
| 2024 10 | 139 | 43 | 182 |
| 2024 9 | 115 | 21 | 136 |
| 2024 8 | 101 | 56 | 157 |
| 2024 7 | 81 | 30 | 111 |
| 2024 6 | 73 | 33 | 106 |
| 2024 5 | 97 | 40 | 137 |
| 2024 4 | 163 | 27 | 190 |
| 2024 3 | 9 | 11 | 20 |
| 2024 2 | 4 | 3 | 7 |
| 2023 11 | 19 | 7 | 26 |
| 2023 10 | 40 | 21 | 61 |
| 2023 9 | 9 | 2 | 11 |
| 2023 8 | 4 | 3 | 7 |
| 2023 6 | 8 | 5 | 13 |
| 2023 5 | 2 | 4 | 6 |
| 2023 4 | 13 | 2 | 15 |
Show all
